Cargando…

Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments

Aβ(40) and Aβ(42) peptides are believed to be associated with Alzheimer’s disease. Aggregates (plaques) of Aβ fibrils are found in the brains of humans affected with this disease. The mechanism of formation of Aβ fibrils has not been studied completely, which hinders the development of a correct str...

Descripción completa

Detalles Bibliográficos
Autores principales: Galzitskaya, Oxana V., Surin, Alexey K., Glyakina, Anna V., Rogachevsky, Vadim V., Selivanova, Olga M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218156/
https://www.ncbi.nlm.nih.gov/pubmed/30480261
http://dx.doi.org/10.3233/ADR-180063
_version_ 1783368415399903232
author Galzitskaya, Oxana V.
Surin, Alexey K.
Glyakina, Anna V.
Rogachevsky, Vadim V.
Selivanova, Olga M.
author_facet Galzitskaya, Oxana V.
Surin, Alexey K.
Glyakina, Anna V.
Rogachevsky, Vadim V.
Selivanova, Olga M.
author_sort Galzitskaya, Oxana V.
collection PubMed
description Aβ(40) and Aβ(42) peptides are believed to be associated with Alzheimer’s disease. Aggregates (plaques) of Aβ fibrils are found in the brains of humans affected with this disease. The mechanism of formation of Aβ fibrils has not been studied completely, which hinders the development of a correct strategy for therapeutic prevention of this neurodegenerative disorder. It has been found that the most toxic samples upon generation of fibrils are different oligomeric formations. Based on different research methods used for studying amyloidogenesis of Aβ(40) and Aβ(42) peptides and its amyloidogenic fragments, we have proposed a new mechanism of formation of amyloid fibrils. In accord with this mechanism, the main building unit for fibril generation is a ring-like oligomer. Association of ring-like oligomers results in the formation of fibrils of different morphologies. Our model implies that to prevent development of Alzheimer’s disease a therapeutic intervention is required at the earliest stages of amyloidogenesis—at the stage of formation of ring-like oligomers. Therefore, the possibility of a personified approach for prevention not only of Alzheimer’s disease development but also of other neurodegenerative diseases associated with the formation of fibrils is argued.
format Online
Article
Text
id pubmed-6218156
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-62181562018-11-26 Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments Galzitskaya, Oxana V. Surin, Alexey K. Glyakina, Anna V. Rogachevsky, Vadim V. Selivanova, Olga M. J Alzheimers Dis Rep Research Article Aβ(40) and Aβ(42) peptides are believed to be associated with Alzheimer’s disease. Aggregates (plaques) of Aβ fibrils are found in the brains of humans affected with this disease. The mechanism of formation of Aβ fibrils has not been studied completely, which hinders the development of a correct strategy for therapeutic prevention of this neurodegenerative disorder. It has been found that the most toxic samples upon generation of fibrils are different oligomeric formations. Based on different research methods used for studying amyloidogenesis of Aβ(40) and Aβ(42) peptides and its amyloidogenic fragments, we have proposed a new mechanism of formation of amyloid fibrils. In accord with this mechanism, the main building unit for fibril generation is a ring-like oligomer. Association of ring-like oligomers results in the formation of fibrils of different morphologies. Our model implies that to prevent development of Alzheimer’s disease a therapeutic intervention is required at the earliest stages of amyloidogenesis—at the stage of formation of ring-like oligomers. Therefore, the possibility of a personified approach for prevention not only of Alzheimer’s disease development but also of other neurodegenerative diseases associated with the formation of fibrils is argued. IOS Press 2018-10-24 /pmc/articles/PMC6218156/ /pubmed/30480261 http://dx.doi.org/10.3233/ADR-180063 Text en © 2018 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Galzitskaya, Oxana V.
Surin, Alexey K.
Glyakina, Anna V.
Rogachevsky, Vadim V.
Selivanova, Olga M.
Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title_full Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title_fullStr Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title_full_unstemmed Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title_short Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
title_sort should the treatment of amyloidosis be personified? molecular mechanism of amyloid formation by aβ peptide and its fragments
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218156/
https://www.ncbi.nlm.nih.gov/pubmed/30480261
http://dx.doi.org/10.3233/ADR-180063
work_keys_str_mv AT galzitskayaoxanav shouldthetreatmentofamyloidosisbepersonifiedmolecularmechanismofamyloidformationbyabpeptideanditsfragments
AT surinalexeyk shouldthetreatmentofamyloidosisbepersonifiedmolecularmechanismofamyloidformationbyabpeptideanditsfragments
AT glyakinaannav shouldthetreatmentofamyloidosisbepersonifiedmolecularmechanismofamyloidformationbyabpeptideanditsfragments
AT rogachevskyvadimv shouldthetreatmentofamyloidosisbepersonifiedmolecularmechanismofamyloidformationbyabpeptideanditsfragments
AT selivanovaolgam shouldthetreatmentofamyloidosisbepersonifiedmolecularmechanismofamyloidformationbyabpeptideanditsfragments